%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Junya Zhai, Yacong Bo, Yan Lu, Chunli Liu, Lishi Zhang
Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 11 0 R/Contents 12 0 R/TrimBox[0 0 612 792]>>
endobj
11 0 obj
[13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R]
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref001)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref002)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref003)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref004)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref007)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.ref009)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0170172.s001)>>
endobj
12 0 obj
[23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
23 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 647.9101 m
199.9998 647.9101 l
199.9998 648.4102 l
575.9997 648.4102 l
f*
0.83 0.64 0.02 0 k
406.4315 551.8488 m
411.1937 551.8488 l
h
f*
231.3638 525.8835 m
236.126 525.8835 l
236.126 525.8268 l
231.3638 525.8268 l
f*
238.3937 525.8835 m
243.1559 525.8835 l
243.1559 525.8268 l
238.3937 525.8268 l
f*
462.4441 525.8835 m
467.1496 525.8835 l
467.1496 525.8268 l
462.4441 525.8268 l
f*
384.4346 473.8394 m
389.1969 473.8394 l
h
f*
301.3795 421.852 m
306.1417 421.852 l
h
f*
471.685 421.852 m
476.4472 421.852 l
h
f*
522.2551 395.8299 m
527.0173 395.8299 l
h
f*
280.5732 382.8472 m
285.3354 382.8472 l
h
f*
404.1071 273.8835 m
452.863 273.8835 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(CoQ10)Tj
3.3597 0 Td
(supplementation)Tj
7.4715 0 Td
(may)Tj
2.0947 0 Td
(partly)Tj
2.6317 0 Td
(improve)Tj
3.7417 0 Td
(the)Tj
1.5934 0 Td
(process)Tj
3.688 0 Td
(of)Tj
1.0444 0 Td
(inflammatory)Tj
5.8841 0 Td
(state.)Tj
2.6496 0 Td
(The)Tj
1.9276 0 Td
(effects)Tj
-36.0864 -1.474 Td
(of)Tj
1.0443 0 Td
(CoQ10)Tj
3.3598 0 Td
(on)Tj
1.3188 0 Td
(inflammation)Tj
5.8245 0 Td
(should)Tj
3.127 0 Td
(be)Tj
1.3129 0 Td
(further)Tj
3.0853 0 Td
(investigated)Tj
5.4902 0 Td
(by)Tj
1.2652 0 Td
(conducting)Tj
4.9949 0 Td
(larger)Tj
2.7391 0 Td
(sample)Tj
3.4076 0 Td
(size)Tj
-36.9696 -1.468 Td
(and)Tj
1.8619 0 Td
(well-defined)Tj
5.4842 0 Td
(trials)Tj
2.2976 0 Td
(of)Tj
1.0503 0 Td
(long)Tj
2.0827 0 Td
(enough)Tj
3.509 0 Td
(duration.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 595.9559 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(1.)Tj
1.0441 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 578.948 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Chronic,)Tj
3.753 0 Td
(low-grade)Tj
4.2293 0 Td
(systematic)Tj
4.3596 0 Td
(inflammation)Tj
5.6976 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(common)Tj
3.8437 0 Td
(pathogenetic)Tj
5.3575 0 Td
(denominator)Tj
5.4708 0 Td
(in)Tj
1.0375 0 Td
(many)Tj
-35.2514 -1.3039 Td
(diseases.)Tj
3.5999 0 Td
(The)Tj
1.7858 0 Td
(elevated)Tj
3.4526 0 Td
(pro-inflammatory)Tj
7.4551 0 Td
(factors,)Tj
3.1238 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(C)Tj
0.8844 0 Td
(reactive)Tj
3.3108 0 Td
(protein)Tj
3.1578 0 Td
(\(CRP\),)Tj
2.965 0 Td
(tumor)Tj
-32.8136 -1.2982 Td
(necrosis)Tj
3.4809 0 Td
(factor-alpha)Tj
5.0513 0 Td
(\(TNF-)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
(\),)Tj
3.9231 0 Td
(interleukin-6)Tj
5.4652 0 Td
(\(IL-6\)[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(],)Tj
3.9855 0 Td
(play)Tj
1.8708 0 Td
(a)Tj
0.652 0 Td
(central)Tj
2.965 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0375 0 Td
(metabolic)Tj
4.1442 0 Td
(dis-)Tj
-34.3443 -1.2983 Td
(eases,)Tj
2.4491 0 Td
(including)Tj
4.0421 0 Td
(obesity,)Tj
3.2599 0 Td
(type)Tj
1.9162 0 Td
(2)Tj
0.6973 0 Td
(diabetes)Tj
3.4582 0 Td
(\(T2DM\),)Tj
3.8438 0 Td
(metabolic)Tj
4.1442 0 Td
(syndrome)Tj
4.235 0 Td
(\(MS\),)Tj
2.4944 0 Td
(cardiovascular)Tj
-30.5402 -1.2983 Td
(disease[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(])Tj
4.8755 0 Td
(\(CVD\))Tj
2.9934 0 Td
(and)Tj
1.7291 0 Td
(nonalcoholic)Tj
5.4085 0 Td
(fatty)Tj
1.9899 0 Td
(liver)Tj
1.9842 0 Td
(disease)Tj
3.0161 0 Td
(\(NAFLD\)[)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
5.5048 0 Td
(Anti-inflammatory)Tj
-27.5015 -1.3039 Td
(agents,)Tj
2.9763 0 Td
(old)Tj
1.4967 0 Td
(drugs)Tj
2.4775 0 Td
(\(salicylates,)Tj
4.7338 0 Td
(especially)Tj
4.0138 0 Td
(salsalate\))Tj
3.7984 0 Td
(and)Tj
1.7348 0 Td
(new)Tj
1.8709 0 Td
(compounds)Tj
4.9606 0 Td
(\(essentially)Tj
4.6261 0 Td
(monoclonal)Tj
-32.6889 -1.2982 Td
(antibodies\),)Tj
4.9265 0 Td
(are)Tj
1.4457 0 Td
(emerging)Tj
4.0082 0 Td
(in)Tj
1.0318 0 Td
(clinical)Tj
3.0784 0 Td
(management)Tj
5.4368 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(related)Tj
2.9424 0 Td
(chronic)Tj
3.2881 0 Td
(inflammatory)Tj
5.709 0 Td
(diseases)Tj
-34.35 -1.2983 Td
(but)Tj
1.5533 0 Td
(the)Tj
1.4684 0 Td
(observed)Tj
3.7927 0 Td
(improvements)Tj
6.0321 0 Td
(appear)Tj
2.9196 0 Td
(rather)Tj
2.6476 0 Td
(modest,)Tj
3.3789 0 Td
(and)Tj
1.7348 0 Td
(questions)Tj
4.0195 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(remained)Tj
4.0308 0 Td
(in)Tj
-35.7616 -1.3039 Td
(poorly)Tj
2.8232 0 Td
(known)Tj
3.0047 0 Td
(long-term)Tj
4.252 0 Td
(safety)Tj
2.4775 0 Td
(and)Tj
1.7291 0 Td
(high)Tj
2.0069 0 Td
(cost)Tj
1.8085 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.6044 0 Td
(Therefore,)Tj
4.3937 0 Td
(it)Tj
0.7823 0 Td
(is)Tj
0.8504 0 Td
(essential)Tj
3.583 0 Td
(to)Tj
1.0261 0 Td
(find)Tj
1.8482 0 Td
(natural)Tj
3.0841 0 Td
(com-)Tj
-35.2741 -1.2983 Td
(pounds)Tj
3.2087 0 Td
(for)Tj
1.3833 0 Td
(substitutions.)Tj
-3.3958 -1.2983 Td
(Coenzyme)Tj
4.473 0 Td
(Q10)Tj
1.9219 0 Td
(\(CoQ10,)Tj
3.651 0 Td
(ubiquinone-10\))Tj
6.497 0 Td
(is)Tj
0.8447 0 Td
(an)Tj
1.2019 0 Td
(endogenously)Tj
5.7599 0 Td
(synthesized)Tj
4.8302 0 Td
(compound)Tj
4.5978 0 Td
(that)Tj
-34.9736 -1.3039 Td
(acts)Tj
1.7347 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(essential)Tj
3.583 0 Td
(cofactor)Tj
3.4752 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4741 0 Td
(mitochondrial)Tj
5.964 0 Td
(electron)Tj
3.4639 0 Td
(transport)Tj
3.9232 0 Td
(system,)Tj
3.1634 0 Td
(a)Tj
0.6576 0 Td
(potent)Tj
2.812 0 Td
(antioxi-)Tj
-33.4996 -1.2982 Td
(dant)Tj
2.0295 0 Td
(of)Tj
1.0148 0 Td
(lipid)Tj
2.041 0 Td
(membranes[)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(])Tj
6.0888 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.6519 0 Td
(modulator)Tj
4.4617 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(gene)Tj
2.0806 0 Td
(expression[)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
5.845 0 Td
(These)Tj
2.5682 0 Td
(functions)Tj
-30.9938 -1.2983 Td
(underlie)Tj
3.5546 0 Td
(the)Tj
1.4683 0 Td
(rationale)Tj
3.7531 0 Td
(for)Tj
1.3833 0 Td
(its)Tj
1.1451 0 Td
(use)Tj
1.5364 0 Td
(in)Tj
1.0318 0 Td
(clinical)Tj
3.0784 0 Td
(practice)Tj
3.3789 0 Td
(and)Tj
1.7291 0 Td
(food)Tj
2.0523 0 Td
(supplement.)Tj
5.125 0 Td
(Previous)Tj
3.6907 0 Td
(study)Tj
-32.927 -1.3039 Td
(reported)Tj
3.6566 0 Td
(CoQ10)Tj
3.0898 0 Td
(tends)Tj
2.3811 0 Td
(to)Tj
1.0261 0 Td
(decrease)Tj
3.6056 0 Td
(hepatic)Tj
3.1125 0 Td
(mRNA)Tj
3.0784 0 Td
(expression)Tj
4.4673 0 Td
(of)Tj
1.0148 0 Td
(IL-6)Tj
1.9219 0 Td
(and)Tj
1.7348 0 Td
(TNF-)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(],)Tj
4.3937 0 Td
(to)Tj
1.0261 0 Td
(attenu-)Tj
-34.5087 -1.2983 Td
(ate)Tj
1.3719 0 Td
(the)Tj
1.474 0 Td
(level)Tj
2.0126 0 Td
(of)Tj
1.0148 0 Td
(CRP[)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
3.4469 0 Td
(Several)Tj
3.0444 0 Td
(randomized)Tj
5.0626 0 Td
(controlled)Tj
4.32 0 Td
(trials)Tj
2.194 0 Td
(\(RCTs\))Tj
3.1578 0 Td
(demonstrated)Tj
5.76 0 Td
(the)Tj
1.474 0 Td
(efficacy)Tj
-34.333 -1.2982 Td
(of)Tj
1.0147 0 Td
(CoQ10)Tj
3.0841 0 Td
(as)Tj
1.0205 0 Td
(an)Tj
1.2019 0 Td
(adjuvant)Tj
3.702 0 Td
(therapeutic)Tj
4.7282 0 Td
(in)Tj
1.0374 0 Td
(metabolic)Tj
4.1443 0 Td
(diseases.)Tj
3.6056 0 Td
(However,)Tj
4.0762 0 Td
(the)Tj
1.4683 0 Td
(results)Tj
2.812 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2563 0 Td
(trials)Tj
-35.1663 -1.2983 Td
(are)Tj
1.4456 0 Td
(inconsistent,)Tj
5.3008 0 Td
(because)Tj
3.3165 0 Td
(of)Tj
1.0148 0 Td
(small)Tj
2.33 0 Td
(sample)Tj
3.0218 0 Td
(sizes)Tj
2.0466 0 Td
(and)Tj
1.7291 0 Td
(uneven)Tj
3.1464 0 Td
(quality.)Tj
3.1805 0 Td
(Therefore,)Tj
4.3936 0 Td
(a)Tj
0.652 0 Td
(meta-analysis)Tj
-31.5777 -1.3039 Td
(of)Tj
1.0147 0 Td
(RCTs)Tj
2.4775 0 Td
(was)Tj
1.6951 0 Td
(conducted)Tj
4.4277 0 Td
(here)Tj
1.9672 0 Td
(to)Tj
1.0262 0 Td
(explore)Tj
3.1748 0 Td
(whether)Tj
3.4752 0 Td
(the)Tj
1.4683 0 Td
(supplementation)Tj
6.9619 0 Td
(of)Tj
1.0148 0 Td
(CoQ10)Tj
3.0841 0 Td
(exhibits)Tj
3.3392 0 Td
(anti-)Tj
-35.1267 -1.2983 Td
(inflammatory)Tj
5.7089 0 Td
(benefits.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 304.9511 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(2.)Tj
1.0441 0 Td
(Materials)Tj
4.5118 0 Td
(and)Tj
1.989 0 Td
(Methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 287.9433 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(meta-analysis)Tj
5.6522 0 Td
(was)Tj
1.7008 0 Td
(conducted)Tj
4.4277 0 Td
(according)Tj
4.1896 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(Preferred)Tj
3.9798 0 Td
(Reporting)Tj
4.2349 0 Td
(Items)Tj
2.4661 0 Td
(for)Tj
1.3833 0 Td
(Systematic)Tj
-32.309 -1.2982 Td
(Reviews)Tj
3.4525 0 Td
(and)Tj
1.7291 0 Td
(Meta-analyses)Tj
5.8847 0 Td
(\(PRISMA\))Tj
4.4731 0 Td
(Guidelines)Tj
4.5297 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(S1)Tj
1.508 0 Td
(Checklist)Tj
0 g
(\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 247.9748 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(2.1)Tj
1.5921 0 Td
(Search)Tj
3.3543 0 Td
(strategy)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 230.9669 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Systematic)Tj
4.473 0 Td
(search)Tj
2.7609 0 Td
(was)Tj
1.7008 0 Td
(conducted)Tj
4.4277 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(PubMed,)Tj
3.8834 0 Td
(MEDLINE,)Tj
4.8246 0 Td
(Web)Tj
2.1203 0 Td
(of)Tj
1.0148 0 Td
(Science,)Tj
3.4299 0 Td
(Cochrane)Tj
-31.1412 -1.2982 Td
(Library)Tj
3.1634 0 Td
(Databases)Tj
4.2066 0 Td
(\(up)Tj
1.6044 0 Td
(to)Tj
1.0261 0 Td
(February)Tj
3.8381 0 Td
(2016\))Tj
2.4605 0 Td
(for)Tj
1.3889 0 Td
(identifying)Tj
4.5751 0 Td
(eligible)Tj
3.0671 0 Td
(studies.)Tj
3.2088 0 Td
(The)Tj
1.7858 0 Td
(following)Tj
3.9798 0 Td
(combi-)Tj
-34.3046 -1.2983 Td
(nation)Tj
2.8232 0 Td
(of)Tj
1.0148 0 Td
(search)Tj
2.761 0 Td
(terms)Tj
2.4944 0 Td
(was)Tj
1.6951 0 Td
(used)Tj
2.0637 0 Td
(in)Tj
1.0318 0 Td
(databases)Tj
4.0025 0 Td
(in)Tj
1.0374 0 Td
(English:)Tj
3.4299 0 Td
(\(Coenzyme)Tj
4.8132 0 Td
(Q10)Tj
1.9162 0 Td
(OR)Tj
1.5874 0 Td
(CoQ10)Tj
3.0898 0 Td
(OR)Tj
1.5874 0 Td
(ubi-)Tj
-35.3478 -1.3039 Td
(quinone-10\))Tj
5.1873 0 Td
(AND)Tj
2.3811 0 Td
(\(inflammation)Tj
6.0378 0 Td
(OR)Tj
1.5874 0 Td
(system)Tj
2.9366 0 Td
(inflammation)Tj
5.6976 0 Td
(OR)Tj
1.5874 0 Td
(IL-6)Tj
1.9276 0 Td
(OR)Tj
1.5874 0 Td
(interleukin-6,)Tj
5.6919 0 Td
(OR)Tj
-34.6221 -1.2983 Td
(CRP)Tj
2.0636 0 Td
(OR)Tj
1.5874 0 Td
(C)Tj
0.8844 0 Td
(reactive)Tj
3.3165 0 Td
(protein)Tj
3.1521 0 Td
(OR)Tj
1.5874 0 Td
(high)Tj
2.0069 0 Td
(sensitive)Tj
3.6283 0 Td
(CRP)Tj
2.0636 0 Td
(OR)Tj
1.5874 0 Td
(hs-CRP)Tj
3.2995 0 Td
(OR)Tj
1.5931 0 Td
(TNF-)Tj
/F11 1 Tf
()Tj
/F7 1 Tf
3.0103 0 Td
(OR)Tj
1.5931 0 Td
(tumor)Tj
2.7439 0 Td
(necrosis)Tj
-34.1175 -1.2982 Td
(factor\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 139.011 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(2.2)Tj
1.5921 0 Td
(Data)Tj
2.3102 0 Td
(selection)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 122.0031 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(All)Tj
1.3946 0 Td
(titles)Tj
2.1146 0 Td
(and)Tj
1.7291 0 Td
(abstracts)Tj
3.7077 0 Td
(were)Tj
2.126 0 Td
(independently)Tj
5.9754 0 Td
(screened)Tj
3.719 0 Td
(by)Tj
1.1849 0 Td
(2)Tj
0.6973 0 Td
(investigators)Tj
5.2724 0 Td
(\(JZ,)Tj
1.7178 0 Td
(YB\))Tj
1.7745 0 Td
(to)Tj
1.0205 0 Td
(evaluate)Tj
3.4639 0 Td
(eli-)Tj
-35.8977 -1.2982 Td
(gibility)Tj
2.9933 0 Td
(for)Tj
1.3833 0 Td
(inclusion)Tj
3.9175 0 Td
(until)Tj
2.1089 0 Td
(consensus)Tj
4.2803 0 Td
(was)Tj
1.7008 0 Td
(reached.)Tj
3.5773 0 Td
(For)Tj
1.6214 0 Td
(a)Tj
0.6576 0 Td
(study)Tj
2.3868 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(systematic)Tj
-33.0234 -1.3039 Td
(review,)Tj
3.067 0 Td
(it)Tj
0.788 0 Td
(had)Tj
1.7065 0 Td
(to)Tj
1.0261 0 Td
(be:)Tj
1.3777 0 Td
(\(1\))Tj
1.3719 0 Td
(RCTs;)Tj
2.7042 0 Td
(\(2\))Tj
1.3777 0 Td
(participants)Tj
4.9549 0 Td
(aged)Tj
2.075 0 Td
(18)Tj
1.1678 0 Td
(years)Tj
2.2677 0 Td
(or)Tj
1.0942 0 Td
(older;)Tj
2.5228 0 Td
(\(3\))Tj
1.3776 0 Td
(intervention)Tj
5.1761 0 Td
(with)Tj
-34.0552 -1.2983 Td
(capsule)Tj
3.1521 0 Td
(of)Tj
1.0148 0 Td
(CoQ10;)Tj
3.3108 0 Td
(\(4\))Tj
1.3776 0 Td
(having)Tj
2.9197 0 Td
(a)Tj
0.652 0 Td
(control)Tj
3.1237 0 Td
(group)Tj
2.6079 0 Td
(with)Tj
1.9956 0 Td
(placebo;)Tj
3.5036 0 Td
(\(5\))Tj
1.3776 0 Td
(minimum)Tj
4.2859 0 Td
(intervention)Tj
5.1817 0 Td
(period)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 391.5779 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Effects)Tj
3.2386 0 Td
(of)Tj
1.0417 0 Td
(Coenzy)Tj
3.3307 0 Td
(me)Tj
1.5945 0 Td
(Q10)Tj
2.0835 0 Td
(on)Tj
1.311 0 Td
(Markers)Tj
3.7772 0 Td
(of)Tj
1.0418 0 Td
(Inflamma)Tj
4.0465 0 Td
(tion)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.4748 0 Td
(DOI:10.137)Tj
5.0387 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.0170)Tj
3.5434 0 Td
(172)Tj
2.6362 0 Td
(January)Tj
3.7134 0 Td
(26,)Tj
1.5874 0 Td
(2017)Tj
37.8003 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
24 0 obj
<>stream
endstream
endobj
25 0 obj
<>stream
endstream
endobj
26 0 obj
<>stream
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
BT
66.402 0 Td
(11)Tj
ET
Q
endstream
endobj
38 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 10 0 R/Annots 42 0 R/Contents 43 0 R/TrimBox[0 0 612 792]>>
endobj
40 0 obj
<>
endobj
44 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
1 beginbfchar
<0121><03C7>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
45 0 obj
<>/FontDescriptor 46 0 R/DW 250/W[289[514]]>>
endobj
46 0 obj
<>
endobj
47 0 obj
<>stream
cvt 0Y "fpgm2Msf bglyfmw head 6hhea $hmtx
loca ` x
maxpx prep
y_<